APYX MEDICAL CORPORATION RECEIVES 510(K) CLEARANCE FOR THE APYX PLASMA/RF HANDPIECEApyxMedical2025-12-12T19:43:03-05:00October 14, 2019|Read More
APYX MEDICAL CORPORATION TO RELEASE THIRD QUARTER OF FISCAL YEAR 2019 FINANCIAL RESULTS ON NOVEMBER 11, 2019ApyxMedical2025-12-12T19:43:26-05:00September 24, 2019|Read More
APYX MEDICAL CORPORATION TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES IN SEPTEMBER AND OCTOBERApyxMedical2025-12-12T19:43:47-05:00August 22, 2019|Read More
APYX MEDICAL CORPORATION REPORTS SECOND QUARTER AND FIRST HALF OF 2019 FINANCIAL RESULTS AND UPDATES FISCAL YEAR 2019 OUTLOOKApyxMedical2025-12-12T19:44:09-05:00August 7, 2019|Read More
APYX MEDICAL CORPORATION ANNOUNCES APPOINTMENT OF MINNIE BAYLOR-HENRY TO THE COMPANY’S BOARD OF DIRECTORSApyxMedical2025-12-12T19:44:31-05:00August 6, 2019|Read More
APYX MEDICAL CORPORATION RECEIVES 510(K) CLEARANCE FOR NEXT-GENERATION J-PLASMA® PRECISE HANDPIECE DESIGNED FOR LAPAROSCOPIC SURGERYApyxMedical2025-12-12T19:44:53-05:00August 5, 2019|Read More
APYX MEDICAL CORPORATION ANNOUNCES NEW ADDITIONS TO CLINICAL AND REGULATORY AFFAIRS TEAMSApyxMedical2025-12-12T19:45:15-05:00July 31, 2019|Read More
APYX MEDICAL CORPORATION ANNOUNCES APPOINTMENT OF FOUR MEMBERS TO ITS MEDICAL ADVISORY BOARDApyxMedical2025-12-12T19:45:35-05:00July 15, 2019|Read More
APYX MEDICAL CORPORATION TO RELEASE SECOND QUARTER OF FISCAL YEAR 2019 FINANCIAL RESULTS ON AUGUST 7, 2019ApyxMedical2025-12-12T19:45:55-05:00July 2, 2019|Read More
APYX MEDICAL CORPORATION JOINS RUSSELL 3000® AND RUSSELL 2000® INDEXESApyxMedical2025-12-12T19:46:18-05:00July 1, 2019|Read More
APYX MEDICAL CORPORATION TO PARTICIPATE IN THE JMP SECURITIES LIFE SCIENCES CONFERENCEApyxMedical2025-12-12T19:46:39-05:00June 4, 2019|Read More
APYX MEDICAL CORPORATION REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS AND UPDATES FISCAL YEAR 2019 OUTLOOKApyxMedical2025-12-12T19:47:02-05:00May 8, 2019|Read More
APYX MEDICAL CORPORATION PROVIDES UPDATE ON THE PREMARKET NOTIFICATION 510(K) SUBMISSION TO THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) FOR USE IN DERMAL RESURFACING PROCEDURES; PROVIDES PRELIMINARY FIRST QUARTER 2019 REVENUE RESULTS AND REAFFIRMS 2019 REVENUE OUTLOOKApyxMedical2025-12-12T19:47:27-05:00April 1, 2019|Read More
APYX MEDICAL CORPORATION TO RELEASE FIRST QUARTER OF FISCAL YEAR 2019 FINANCIAL RESULTS ON MAY 8, 2019ApyxMedical2025-12-12T19:47:50-05:00April 1, 2019|Read More
APYX MEDICAL CORPORATION TO RELEASE FOURTH QUARTER AND FISCAL YEAR 2018 FINANCIAL RESULTS ON MARCH 13, 2019ApyxMedical2025-12-12T19:48:36-05:00February 7, 2019|Read More
APYX MEDICAL CORPORATION ANNOUNCES THE PROMOTION OF TODD HORNSBY TO EXECUTIVE VICE PRESIDENTApyxMedical2025-12-12T19:48:59-05:00January 14, 2019|Read More
